/
APYX
$4.69+$0.19 (+4.22%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$188.4M
42M shares
52-week range
$1.59 – $5.08
89% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
1.22%
Moderate
Price (6 mo)
Loading chart…
Change$-5.95
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.7M | $28.2M | $27.7M | $48.5M | $44.5M | $52.3M | $48.1M | $52.8M |
| Cost of revenue | $5.9M | $9.1M | $10.2M | $14.9M | $15.4M | $18.6M | $18.7M | $33.8M |
| Gross profit | $10.8M | $19.1M | $17.5M | $33.6M | $29.1M | $33.8M | $29.4M | $19.0M |
| Gross margin | 64.7% | 67.6% | 63.2% | 69.3% | 65.4% | 64.5% | 61.0% | 36.0% |
| R&D | $2.5M | $3.7M | $3.9M | $4.3M | $4.5M | $4.8M | $5.1M | $3.4M |
| Operating income | −$13.6M | −$20.9M | −$20.1M | −$14.4M | −$23.6M | −$17.3M | −$18.8M | −$6.4M |
| EBITDA | −$13.9M | −$19.1M | −$18.5M | −$13.9M | −$22.0M | −$18.1M | −$16.8M | −$4.6M |
| Net income | $64.0M | −$19.7M | −$11.9M | −$15.2M | −$23.2M | −$18.7M | −$23.5M | −$11.2M |
| Net margin | 383.6% | -69.8% | -42.9% | -31.3% | -52.1% | -35.7% | -48.8% | -21.2% |
| EPS (diluted) | 1.86 | -0.58 | -0.35 | -0.44 | -0.67 | -0.54 | -0.66 | -0.27 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $60M | $-0.28 | $-0.28–$-0.28 | 3 |
| 2027 | $66M | $-0.26 | $-0.27–$-0.26 | 3 |
| 2028 | $76M | $-0.11 | $-0.11–$-0.10 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Apyx Medical Corporation Common Stock
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
apyxmedical.com- Employees
- 205
- IPO / List date
- Apr 6, 1994
- HQ
- CLEARWATER, FL
Held by traders on TradeandTell
No one on the platform currently holds APYX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 302,395 | $1.1M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded APYX yet.
